Literature DB >> 26377248

Ustekinumab as therapy for psoriasis in a 2-year-old girl.

M S Min1,2, A Shroff1, S Rose1, M Lebwohl1, E Guttman-Yassky3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26377248     DOI： 10.1111/jdv.13348

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  4 in total

1.  Tumor Necrosis Factor Inhibitor-Induced Psoriasis in a Pediatric Crohn's Disease Patient Successfully Treated with Ustekinumab.

Authors:  Lauren Bonomo; Ellen H de Moll; Linden Li; Lauren Geller; Michael I Gordon; David Dunkin
Journal:  J Drugs Dermatol       Date:  2020-03-01       Impact factor: 2.114

Review 2.  CARD14-associated papulosquamous eruption (CAPE) in pediatric patients: Three additional cases and review of the literature.

Authors:  Cindy P Frare; Alli J Blumstein; Amy S Paller; Lia Pieretti; Keith A Choate; Anne M Bowcock; Margarita Larralde
Journal:  Pediatr Dermatol       Date:  2021-08-26       Impact factor: 1.997

3.  Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin.

Authors:  Medek Katharina; Selhofer Sylvia; Buchner Matthias; Mrowietz Ulrich; Laimer Martin
Journal:  Pediatr Dermatol       Date:  2022-07-20       Impact factor: 1.997

4.  Successful treatment of juvenile pityriasis rubra pilaris with ustekinumab in a 7-year-old girl.

Authors:  Lauren Bonomo; Aishwarya Raja; Kathryn Tan; Emma Guttman-Yassky
Journal:  JAAD Case Rep       Date:  2018-02-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.